<scp>GLP</scp> ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
The use of GLP-1RAs was associated with lower rates of cardiovascular events than no use in patients with MUHO. Similar but non-statistically significant trends were seen in patients with MHO.
Authors
- Uazman Alam (ORCID: https://orcid.org/0000-0002-3190-1122)
- Tommaso Bucci (ORCID: https://orcid.org/0000-0003-2895-6234)
- Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
- Laurent Fauchier (ORCID: https://orcid.org/0000-0002-9267-1658)
- Arnaud Bisson (ORCID: https://orcid.org/0000-0002-3449-1800)
- Grégoire Fauchier
- Pierre Henri Ducluzeau
- Lisa Lochon (ORCID: https://orcid.org/0009-0000-6006-6034)
Institutions
- Université de Tours (FR)
- University of Liverpool (GB)
- University of Staffordshire (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- Liverpool Heart and Chest Hospital (GB)
- Centre Hospitalier Universitaire de Tours (FR)
- Centre hospitalier universitaire d'Orléans (FR)
- Liverpool John Moores University (GB)
- Sapienza University of Rome (IT)
- Aalborg University (DK)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-02-10
- DOI
- https://doi.org/10.1111/dom.16238
- Citations
- 8
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 10.36